Similar Articles
Sacroiliitis in Systemic Lupus Erythematosus Revisited
Neslihan YILMAZ, Ayten YAZICI, Banu ÖZULU TÜRKMEN, Işık KARALOK, Şule YAVUZ
DOI: 10.46497/ArchRheumatol.2020.7514
Concomitant Autoimmune Diseases in Patients With Sarcoidosis in Turkey
Fidan YILDIZ, Şenol KOBAK, Hüseyin SEMİZ, Mehmet ORMAN
DOI: 10.46497/ArchRheumatol.2020.7649
Sarcoidosis in Jordan: A Study of the Clinical Phenotype and Disease Outcome
Fatima ALNAIMAT, Khaled AL OWEIDAT, Anas ALRWASHDEH, Ahmad ALNASHRATI, Saba BARHAM, Mohammad HIJAZ, Dina MURAD, Sameeha ALSHELLEH, Nathir OBEIDAT
DOI: 10.46497/ArchRheumatol.2020.7584
Serum B cell activating factor (BAFF) and sarcoidosis activity
Kamila HASHEMZADEH, Maryam FATEMIPOUR, Seyede ZAHRA MIRFEIZI, Mohammadhasan JOKAR, Zhaleh SHARIATI SARABI, Mohammad-Reza HATEF FARD, Houshang RAFATPANAH, Mandana KHODASHAHI
DOI: 10.46497/ArchRheumatol.2021.8013
The Role of Sacroiliac Joint Steroid Injections in the Treatment of Axial Spondyloarthritis
Serdar KOKAR, Önder KAYHAN, Savaş ŞENCAN, Osman Hakan GÜNDÜZ
DOI: 10.46497/ArchRheumatol.2021.8043
Evaluation of musculoskeletal adverse effects in patients on systemic isotretinoin treatment: A cross-sectional study
Emine Müge Acar, Senem Şaş, Fatmanur Aybala Koçak
DOI: 10.46497/ArchRheumatol.2022.8645
Investigation of the relationship between interferon-gamma receptor 1-56C/T gene polymorphism and genetic susceptibility to lung sarcoidosis: A cross-sectional study
Serdar Kaymaz, Murat Kavas, Aydın Demiray, Uğur Karasu, Veli Çobankara, Sibel Boğa
DOI: 10.46497/ArchRheumatol.2022.9239